Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novavax Inc. buy quelbe60

Start price
€151.40
12.12.21 / 50%
Target price
-
12.12.22
Performance (%)
5.67%
End price
€159.98
25.12.21
Summary
This prediction ended on 25.12.21 with a price of €159.98. The BUY prediction by quelbe60 finished with a performance of 5.67%. quelbe60 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Novavax Inc. -9.013% -9.013% -56.805%
iShares Core DAX® -1.670% -1.001% 10.864%
iShares Nasdaq 100 -4.184% -1.145% 37.458%
iShares Nikkei 225® -4.967% -5.783% 18.828%
iShares S&P 500 -2.834% -0.572% 25.875%

According to quelbe60 what are the pros and cons of Novavax Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by quelbe60 for this prediction

In the thread Novavax Inc. diskutieren

Buy Novavax Inc.

In the thread Trading Novavax Inc.
Prediction Buy
Perf. (%) 5.67%
Target price
Change
Ends at 12.12.22

Buy beendet

Stopped prediction by quelbe60 for Novavax Inc.

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€3.75
29.01.24
-
29.01.25
-2.03%
03.02.24

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€6.62
01.03.23
-
01.03.24
-15.51%
17.03.23

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€74.55
23.01.22
-
23.01.23
7.12%
06.02.22

Could be very worthwhile Investment >20% year